Researchers have found a link between low testosterone levels and aggressive tumors, which could change how prostate cancer ...

A silent killer that is the second leading cause of death among American men, prostate cancer is a disease that has recently come to the forefront of medical research. Studies and new reviews are ...

Several experimental prostate cancer drugs have produced striking results in early-stage clinical trials, with at least one ...

Stage 2 prostate adenocarcinoma is localized, with a nearly 100%, five-year relative survival rate. Diagnosis uses the TNM system, PSA levels and Gleason score to determine cancer stage and risk.

When prostate cancer has spread beyond the prostate to nearby lymph nodes and other areas of the body and treatments can no longer slow or stop its growth, you are not alone. Many patients, despite ...

UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...

Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting ...

Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing ...

The Chartered Institute of Building has teamed up with a men’s health charity to encourage more men working in the ...